# An Exploratory stuDy of effectIveneSs and Safety of rivarOxaban in Patients With Left VEntricular Thrombus (R-DISSOLVE)

> **NCT04970381** · NA · COMPLETED · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 75 (actual)

## Conditions studied

- Ventricular Mural Thrombosis

## Interventions

- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT04970381
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-27
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04970381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04970381, "An Exploratory stuDy of effectIveneSs and Safety of rivarOxaban in Patients With Left VEntricular Thrombus (R-DISSOLVE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04970381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*